|
1
|
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.
|
Circulation
|
2003
|
3.68
|
|
2
|
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
|
Cancer Res
|
2003
|
2.70
|
|
3
|
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons.
|
FASEB J
|
2007
|
2.63
|
|
4
|
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2006
|
2.45
|
|
5
|
Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
|
Magn Reson Med
|
2005
|
2.30
|
|
6
|
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
|
JACC Cardiovasc Imaging
|
2008
|
2.14
|
|
7
|
Nanotechnological applications in medicine.
|
Curr Opin Biotechnol
|
2007
|
1.90
|
|
8
|
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.
|
Magn Reson Med
|
2004
|
1.83
|
|
9
|
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.
|
J Clin Invest
|
2009
|
1.78
|
|
10
|
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.
|
Magn Reson Med
|
2004
|
1.68
|
|
11
|
Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
|
FASEB J
|
2008
|
1.67
|
|
12
|
Paracrine induction of endothelium by tumor exosomes.
|
Lab Invest
|
2009
|
1.63
|
|
13
|
Computed tomography in color: NanoK-enhanced spectral CT molecular imaging.
|
Angew Chem Int Ed Engl
|
2010
|
1.57
|
|
14
|
Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.
|
Int J Cancer
|
2007
|
1.57
|
|
15
|
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles.
|
Magn Reson Med
|
2008
|
1.56
|
|
16
|
Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles.
|
ACS Nano
|
2010
|
1.53
|
|
17
|
Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides.
|
Nano Lett
|
2008
|
1.47
|
|
18
|
Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus.
|
J Am Chem Soc
|
2011
|
1.47
|
|
19
|
Molecular photoacoustic tomography with colloidal nanobeacons.
|
Angew Chem Int Ed Engl
|
2009
|
1.47
|
|
20
|
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
|
J Magn Reson Imaging
|
2007
|
1.46
|
|
21
|
Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.
|
FASEB J
|
2010
|
1.42
|
|
22
|
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
|
FASEB J
|
2008
|
1.41
|
|
23
|
Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
|
Ann Biomed Eng
|
2009
|
1.39
|
|
24
|
Nanotechnology for molecular imaging and targeted therapy.
|
Circulation
|
2003
|
1.38
|
|
25
|
Improved molecular imaging contrast agent for detection of human thrombus.
|
Magn Reson Med
|
2003
|
1.37
|
|
26
|
Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets.
|
J Am Chem Soc
|
2008
|
1.31
|
|
27
|
In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla.
|
Invest Radiol
|
2006
|
1.29
|
|
28
|
Molecular imaging, targeted therapeutics, and nanoscience.
|
J Cell Biochem Suppl
|
2002
|
1.28
|
|
29
|
Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons.
|
Biomaterials
|
2010
|
1.27
|
|
30
|
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
|
Magn Reson Med
|
2006
|
1.25
|
|
31
|
Molecular imaging of human thrombus with computed tomography.
|
Acad Radiol
|
2005
|
1.21
|
|
32
|
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.
|
J Biol Chem
|
2010
|
1.20
|
|
33
|
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
|
Magn Reson Med
|
2008
|
1.19
|
|
34
|
Conquering the dark side: colloidal iron oxide nanoparticles.
|
ACS Nano
|
2009
|
1.18
|
|
35
|
High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
|
Invest Radiol
|
2009
|
1.15
|
|
36
|
Targeted ultrasonic contrast agents for molecular imaging and therapy.
|
Curr Probl Cardiol
|
2003
|
1.15
|
|
37
|
Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2006
|
1.14
|
|
38
|
Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
|
FASEB J
|
2009
|
1.13
|
|
39
|
Nanomedicine: perspective and promises with ligand-directed molecular imaging.
|
Eur J Radiol
|
2009
|
1.13
|
|
40
|
Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.
|
Biomaterials
|
2008
|
1.12
|
|
41
|
Imaging atherosclerosis and vulnerable plaque.
|
J Nucl Med
|
2010
|
1.10
|
|
42
|
Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents.
|
Magn Reson Med
|
2011
|
1.10
|
|
43
|
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
|
Int J Nanomedicine
|
2007
|
1.09
|
|
44
|
Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
|
Magn Reson Med
|
2008
|
1.09
|
|
45
|
Revisiting an old friend: manganese-based MRI contrast agents.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2010
|
1.09
|
|
46
|
Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle.
|
J Am Chem Soc
|
2009
|
1.08
|
|
47
|
Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.
|
Ultrasound Med Biol
|
2005
|
1.08
|
|
48
|
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
|
J Cardiovasc Magn Reson
|
2007
|
1.07
|
|
49
|
Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.
|
J Acoust Soc Am
|
2005
|
1.07
|
|
50
|
Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver.
|
Ultrasound Med Biol
|
2007
|
1.07
|
|
51
|
Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.
|
Arterioscler Thromb Vasc Biol
|
2008
|
1.07
|
|
52
|
Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling.
|
Biomaterials
|
2011
|
1.04
|
|
53
|
Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids.
|
Chem Commun (Camb)
|
2009
|
1.03
|
|
54
|
Manganese-based MRI contrast agents: past, present and future.
|
Tetrahedron
|
2011
|
1.02
|
|
55
|
Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.
|
IEEE Trans Med Imaging
|
2010
|
1.02
|
|
56
|
Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
|
Expert Rev Med Devices
|
2007
|
1.02
|
|
57
|
Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.
|
Biomaterials
|
2010
|
1.02
|
|
58
|
Programmable nanoparticle functionalization for in vivo targeting.
|
FASEB J
|
2012
|
1.01
|
|
59
|
An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging.
|
ACS Nano
|
2012
|
1.00
|
|
60
|
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2002
|
1.00
|
|
61
|
Characterization of digital waveforms using thermodynamic analogs: applications to detection of materials defects.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2005
|
1.00
|
|
62
|
Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2007
|
1.00
|
|
63
|
Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.
|
Ultrasound Med Biol
|
2007
|
1.00
|
|
64
|
Quantitative magnetic resonance fluorine imaging: today and tomorrow.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2010
|
1.00
|
|
65
|
Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.
|
FASEB J
|
2010
|
1.00
|
|
66
|
Nanomedicine strategies for molecular targets with MRI and optical imaging.
|
Future Med Chem
|
2010
|
0.99
|
|
67
|
Molecular imaging by MRI.
|
Curr Cardiol Rep
|
2006
|
0.97
|
|
68
|
Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
|
Radiology
|
2013
|
0.97
|
|
69
|
Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2010
|
0.96
|
|
70
|
Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.
|
Nanomedicine (Lond)
|
2010
|
0.95
|
|
71
|
Angiogenesis is required for stress fracture healing in rats.
|
Bone
|
2012
|
0.95
|
|
72
|
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.
|
MRS Bull
|
2009
|
0.95
|
|
73
|
Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.
|
Nanomedicine (Lond)
|
2010
|
0.94
|
|
74
|
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.
|
Biomaterials
|
2012
|
0.93
|
|
75
|
Application of a real-time, calculable limiting form of the Renyi entropy for molecular imaging of tumors.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2010
|
0.92
|
|
76
|
Photoacoustic sentinel lymph node imaging with self-assembled copper neodecanoate nanoparticles.
|
ACS Nano
|
2012
|
0.92
|
|
77
|
Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
|
Nanomedicine (Lond)
|
2012
|
0.91
|
|
78
|
Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound.
|
J Am Coll Cardiol
|
2004
|
0.91
|
|
79
|
MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.
|
FASEB J
|
2010
|
0.91
|
|
80
|
Melittin derived peptides for nanoparticle based siRNA transfection.
|
Biomaterials
|
2013
|
0.91
|
|
81
|
Spectral properties of a bifunctional PARACEST europium chelate: an intermediate for targeted imaging applications.
|
Contrast Media Mol Imaging
|
2007
|
0.91
|
|
82
|
Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2011
|
0.91
|
|
83
|
Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS.
|
J Cardiovasc Magn Reson
|
2008
|
0.90
|
|
84
|
Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.
|
Magn Reson Med
|
2010
|
0.90
|
|
85
|
A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.
|
Nanomedicine (Lond)
|
2011
|
0.90
|
|
86
|
Temperature dependence of acoustic impedance for specific fluorocarbon liquids.
|
J Acoust Soc Am
|
2002
|
0.89
|
|
87
|
Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
|
Magn Reson Med
|
2008
|
0.89
|
|
88
|
Use of smoothing splines for analysis of backscattered ultrasonic waveforms: application to monitoring of steroid treatment of dystrophic mice.
|
IEEE Trans Ultrason Ferroelectr Freq Control
|
2011
|
0.89
|
|
89
|
A Green Synthesis of Carbon Nanoparticle from Honey for Real-Time Photoacoustic Imaging.
|
Nano Res
|
2013
|
0.88
|
|
90
|
MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.
|
J Cardiovasc Magn Reson
|
2006
|
0.87
|
|
91
|
A generalized strategy for designing (19)F/(1)H dual-frequency MRI coil for small animal imaging at 4.7 Tesla.
|
J Magn Reson Imaging
|
2011
|
0.87
|
|
92
|
Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging.
|
Contrast Media Mol Imaging
|
2011
|
0.87
|
|
93
|
Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity.
|
IEEE Trans Nanobioscience
|
2006
|
0.86
|
|
94
|
Targeted magnetic resonance imaging contrast agents.
|
Methods Mol Med
|
2006
|
0.86
|
|
95
|
Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.
|
ACS Nano
|
2014
|
0.86
|
|
96
|
Molecular imaging by cardiovascular MR.
|
J Cardiovasc Magn Reson
|
2007
|
0.85
|
|
97
|
Postformulation peptide drug loading of nanostructures.
|
Methods Enzymol
|
2012
|
0.84
|
|
98
|
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function.
|
FASEB J
|
2014
|
0.84
|
|
99
|
Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation.
|
J Magn Reson Imaging
|
2011
|
0.84
|
|
100
|
Quantitative cardiovascular magnetic resonance for molecular imaging.
|
J Cardiovasc Magn Reson
|
2010
|
0.84
|
|
101
|
Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model.
|
Contrast Media Mol Imaging
|
2010
|
0.84
|
|
102
|
Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles.
|
NMR Biomed
|
2011
|
0.83
|
|
103
|
Surface passivation of carbon nanoparticles with branched macromolecules influences near infrared bioimaging.
|
Theranostics
|
2013
|
0.83
|
|
104
|
MR molecular imaging of aortic angiogenesis.
|
JACC Cardiovasc Imaging
|
2010
|
0.82
|
|
105
|
Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
|
Expert Rev Cardiovasc Ther
|
2005
|
0.82
|
|
106
|
Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.
|
Angiogenesis
|
2013
|
0.82
|
|
107
|
Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence.
|
Magn Reson Med
|
2012
|
0.81
|
|
108
|
Interaction of melittin peptides with perfluorocarbon nanoemulsion particles.
|
J Phys Chem B
|
2011
|
0.81
|
|
109
|
A facile synthesis of novel self-assembled gold nanorods designed for near-infrared imaging.
|
J Nanosci Nanotechnol
|
2010
|
0.81
|
|
110
|
Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles.
|
Magn Reson Med
|
2013
|
0.80
|
|
111
|
Angiogenesis and airway reactivity in asthmatic Brown Norway rats.
|
Angiogenesis
|
2014
|
0.80
|
|
112
|
Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons.
|
Contrast Media Mol Imaging
|
2014
|
0.80
|
|
113
|
Antagonizing the αv β3 integrin inhibits angiogenesis and impairs woven but not lamellar bone formation induced by mechanical loading.
|
J Bone Miner Res
|
2014
|
0.80
|
|
114
|
Ultrasonic delineation of aortic microstructure: the relative contribution of elastin and collagen to aortic elasticity.
|
J Acoust Soc Am
|
2004
|
0.79
|
|
115
|
A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.
|
Nanomedicine (Lond)
|
2015
|
0.79
|
|
116
|
Nanotechnology in interventional cardiology.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2011
|
0.78
|
|
117
|
A brief account of nanoparticle contrast agents for photoacoustic imaging.
|
Wiley Interdiscip Rev Nanomed Nanobiotechnol
|
2013
|
0.78
|
|
118
|
Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.
|
Adv Chronic Kidney Dis
|
2013
|
0.77
|
|
119
|
Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.
|
Soft Matter
|
2012
|
0.77
|
|
120
|
Rapid synthesis of near infrared polymeric micelles for real-time sentinel lymph node imaging.
|
Adv Healthc Mater
|
2012
|
0.77
|
|
121
|
Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent.
|
Acad Radiol
|
2002
|
0.76
|
|
122
|
Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.
|
PLoS One
|
2012
|
0.76
|
|
123
|
ICAM-1 and nanomedicine: nature's doorway to the extravascular tissue realm.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.75
|
|
124
|
Clinical utility of rapid prescreening magnetic resonance angiography of peripheral vascular disease prior to cardiac catheterization.
|
J Cardiovasc Magn Reson
|
2004
|
0.75
|
|
125
|
Emerging contrast agents for photoacoustic imaging.
|
Contrast Media Mol Imaging
|
2011
|
0.75
|
|
126
|
Nanotechnology in the diagnosis of atherosclerotic disease.
|
Expert Opin Med Diagn
|
2008
|
0.75
|